Literature DB >> 19558618

Neurofibromatosis type 1: should we screen for other genetic syndromes? A case report of co-existence with multiple endocrine neoplasia 2A.

E Gkaliagkousi1, Z Erlic, K Petidis, P Semertzidis, M Doumas, C Zamboulis, H P H Neumann, S Douma.   

Abstract

BACKGROUND: NF 1 is a genetic disorder with an autosomal dominant pattern of inheritence. It is associated with neoplastic disorders mainly derived from the neural seath. However, the co-existence of NF1 with the full spectrum of MEN 2A has rarely been reported. The aim of the study was to investigate the presence of secondary neoplasias in a patient with diagnosed NF1, and in particular the presence of hyperparathyroidism and the possible co-existence with another pheochromocytoma-related syndrome.
METHODS: We report a case of a 70 years old female patient who had NF1. The patient was referred to our center and was diagnosed with an isolated pheochromocytoma of the right adrenal gland for which she underwent right adrenalectomy. We further investigated for the presence of another pheochromocytoma-related syndrome and in particular for the presence of hyperparathyroidism and medullary thyroid cancer. Molecular screening for germline mutations of the genes NF1, RET and VHL has also been performed.
RESULTS: The patient was further diagnosed with hyperparathyroidism and medullary thyroid cancer, having the full spectrum of the clinical picture of the MEN2A syndrome. The genetic testing revealed the germline mutation for NF1 but not for the RET proto-oncogene which is generally found in MEN2A cases.
CONCLUSION: To our knowledge this is a rare case of co-existence of two pheochromocytoma-related genetic syndromes, and generates the question of whether all patients with these syndromes should undergo a thorough clinical and laboratory investigation for the possibility of another co-existing pheochromocytoma-related genetic syndrome.

Entities:  

Mesh:

Year:  2009        PMID: 19558618     DOI: 10.1111/j.1365-2362.2009.02174.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  Concurrent primary hyperparathyroidism and pheochromocytoma in a Chinese lady with neurofibromatosis type 1.

Authors:  Cheuk-Lik Wong; Chun-Kit Fok; Vicki Ho-Kee Tam
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-03-28

2.  Laparoscopic retroperitoneal resection of the duodenal gastrointestinal stromal tumors in neurofibromatosis type 1; Case Report and literature review.

Authors:  Al-Danakh Abdullah; Safi Mohammed; Mohammed Alradhi; Xinqing Zhu; Deyong Yang
Journal:  Front Surg       Date:  2022-08-26

3.  Thyroid Gland 18F-FDG Uptake in Neurofibromatosis Type 1.

Authors:  Zoë Y G J van Lierop; Sander Jentjens; Monique H M E Anten; Roel Wierts; Connie T Stumpel; Bas Havekes; Marinus J P G van Kroonenburgh
Journal:  Eur Thyroid J       Date:  2018-06-05

4.  Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?

Authors:  Adila Alkindy; Nadia Chuzhanova; Usha Kini; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2012-08-13       Impact factor: 4.639

5.  A Pleural Solitary Fibrous Tumor, Multiple Gastrointestinal Stromal Tumors, Moyamoya Disease, and Hyperparathyroidism in a Patient Associated with NF1.

Authors:  Yoko Yamamoto; Ken Kodama; Shigekazu Yokoyama; Masashi Takeda; Shintaro Michishita
Journal:  Case Rep Surg       Date:  2015-09-13

Review 6.  Gastrinoma and neurofibromatosis type 2: the first case report and review of the literature.

Authors:  Sara Massironi; Alessandra Zilli; Roberta Elisa Rossi; Federica Cavalcoli; Dario Conte; Maddalena Peracchi
Journal:  BMC Gastroenterol       Date:  2014-06-24       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.